Biomoda Inc. (BMOD.OB) is “One to Watch”
Biomoda, Inc.(OTCBB: BMOD) is a biopharmaceutical company engaged with early cancer detection technology. The Company’s cell-targeting technology is patented around the world for the detection of pre-cancerous and cancerous conditions in all human tissue. The technology was developed at Los Alamos National Laboratories. Biomoda acquired a worldwide license to the technology from the University of California in late 1995, and then began finding new ways to broaden the scope of the original patent and technology. The company's diagnostic kit staining procedure reveals the unique cell-targeting characteristics of porphyrins. When certain wavelengths of fluorescent light are beamed on the ink, Biomoda’s…